Viridian Therapeutics Inc (VRDN)
13.01
+0.23
(+1.80%)
USD |
NASDAQ |
Jun 28, 16:00
13.00
-0.01
(-0.08%)
After-Hours: 20:00
Viridian Therapeutics Total Assets (Quarterly): 630.38M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 630.38M |
| December 31, 2023 | 490.42M |
| September 30, 2023 | 328.76M |
| June 30, 2023 | 351.47M |
| March 31, 2023 | 386.64M |
| December 31, 2022 | 435.09M |
| September 30, 2022 | 440.58M |
| June 30, 2022 | 169.81M |
| March 31, 2022 | 183.16M |
| December 31, 2021 | 203.71M |
| September 30, 2021 | 221.20M |
| June 30, 2021 | 118.20M |
| March 31, 2021 | 122.83M |
| December 31, 2020 | 131.26M |
| September 30, 2020 | 32.83M |
| June 30, 2020 | 33.48M |
| March 31, 2020 | 39.05M |
| December 31, 2019 | 30.26M |
| September 30, 2019 | 38.81M |
| June 30, 2019 | 48.78M |
| March 31, 2019 | 54.95M |
| Date | Value |
|---|---|
| December 31, 2018 | 66.15M |
| September 30, 2018 | 76.55M |
| June 30, 2018 | 81.89M |
| March 31, 2018 | 86.99M |
| December 31, 2017 | 52.48M |
| September 30, 2017 | 47.08M |
| June 30, 2017 | 50.03M |
| March 31, 2017 | 57.79M |
| December 31, 2016 | 4.259M |
| September 30, 2016 | 7.541M |
| June 30, 2016 | 9.042M |
| March 31, 2016 | 10.80M |
| December 31, 2015 | 12.90M |
| September 30, 2015 | 14.80M |
| June 30, 2015 | 13.09M |
| March 31, 2015 | 15.75M |
| December 31, 2014 | 8.089M |
| September 30, 2014 | 9.525M |
| June 30, 2014 | 10.66M |
| March 31, 2014 | 3.495M |
| December 31, 2013 | 3.673M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
30.26M
Minimum
Dec 2019
630.38M
Maximum
Mar 2024
230.95M
Average
183.16M
Median
Mar 2022
Total Assets (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 278.29M |
| Electromed Inc | 48.90M |
| Xtant Medical Holdings Inc | 93.93M |
| Asensus Surgical Inc | 40.81M |
| Myomo Inc | 16.52M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 47.85M |
| Shareholders Equity (Quarterly) | 582.53M |
| Debt to Equity Ratio | 0.0349 |
| Current Ratio | 23.99 |
| Net Debt Paydown Yield | -0.28% |